錦欣生殖(1951.HK)獲納入富時亞太地區(日本除外)ESG低碳選擇指數
格隆匯9月13日丨富時國際公司公佈FTSE ESG Low Carbon Target Exposure Select Indexes成分股調整結果顯示,中國輔助生殖服務商錦欣生殖(1951.HK)被納入富時亞太地區(日本除外)ESG低碳選擇指數(FTSE Asia ex Japan ESG Low Carbon Select Index),調整將於9月20日生效。富時亞太地區(日本除外)ESG低碳選擇指數系列由亞太地區(不包括日本股票)的中大型股票組成,目標是指數級碳排放減少50%,化石燃料儲量減少50%,指數級ESG評級提高20%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.